Carotid atherosclerosis or nonalcoholic fatty liver disease: Which comes first?

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 187-188

  Dogru, Teoman ^a   Genc, Halil ^b   Ercin, Cemal Nuri ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Izmir Military Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL WALL THICKNESS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAROTID ARTERY; CAROTID ARTERY INTIMA MEDIA THICKNESS; CAROTID ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; HUMAN; HYPERTENSION; LETTER; LIVER BIOPSY; LIVER INJURY; LONGITUDINAL STUDY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

CARDIOVASCULAR DISEASES; FATTY LIVER; HUMANS;

EID: 84888107997     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.09.012     Document Type: Letter

References (30)

1. Oni E.T., Agatston A.S., Blaha M.J., et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?. Atherosclerosis 2013, 230:258-267.
2. Sookoian S., Pirola C.J. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008, 49:600-607.
3. Kelishadi R., Cook S.R., Amra B., et al. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis 2009, 204:538-543.
4. Kucukazman M., Ata N., Yavuz B., et al. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2013, 25:147-151.
5. Thakur M.L., Sharma S., Kumar A., et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 2012, 223:507-511.
6. Li X., Xia M., Ma H., et al. Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. Atherosclerosis 2012, 224:480-485.
7. Colak Y., Senates E., Yesil A., et al. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine 2013, 43:100-107.
8. Brea A., Mosquera D., Martín E., et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005, 25:1045-1050.
9. Targher G., Bertolini L., Padovani R., et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29:1325-1330.
10. Dick T.J., Lesser I.A., Leipsic J.A., et al. The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. Atherosclerosis 2013, 226:208-213.
11. McKimmie R.L., Daniel K.R., Carr J.J., et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008, 103:3029-3035.
12. Petit J.M., Guiu B., Terriat B., et al. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. J Clin Endocrinol Metab 2009, 94:4103-4106.
13. Genc H., Dogru T., Celebi G., et al. Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis. Gulhane Med J 2013, 55:84-88.
14. Dogru T., Genc H., Tapan S., et al. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 2013, 78:712-717.
15. Dogru T., Genc H., Tapan S., et al. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?. Diabetes Res Clin Pract 2012, 96:47-52.
16. Schwenzer N.F., Springer F., Schraml C., et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009, 51:433-445.
17. Park S.W., Kim S.K., Cho Y.W., et al. Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2009, 205:309-313.
18. Paras E., Mancini G.B., Lear S.A. The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis. Atherosclerosis 2008, 198:228-236.
19. Kim H.C., Kim D.J., Huh K.B. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009, 204:521-525.
20. Martens F.M., van der Graaf Y., Dijk J.M., Olijhoek J.K., Visseren F.L. Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease. Atherosclerosis 2008, 197:646-653.
21. Lorenz M.W., Markus H.S., Bots M.L., et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
22. Kilciler G., Genc H., Tapan S., et al. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Ups J Med Sci 2010, 115:253-259.
23. Kara M., Genc H., Dogru T., et al. Comparison of the asymmetric dimethyl arginin levels and carotid intima media thickness with hemoglobin levels in patients with non-alcholic fatty liver disease. Gulhane Med J 2012, 54:40-48.
24. Manco M., Bedogni G., Monti L., et al. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis 2010, 209:463-468.
25. Kollias A., Stergiou G.S., Dolan E., O'Brien E. Ambulatory arterial stiffness index: a systematic review and meta-analysis. Atherosclerosis 2012, 224:291-301.
26. Balletshofer B.M., Rittig K., Stock J., et al. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003, 171:303-309.
27. Villanova N., Moscatiello S., Ramilli S., et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005, 42:473-480.
28. Pacifico L., Anania C., Martino F., et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 2010, 52:1643-1651.
29. Younossi Z.M., Otgonsuren M., Venkatesan C., Mishra A. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 2013, 62:352-360.
30. Yilmaz Y. Review article: is non-alcoholic fatty liver diseasea spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?. Aliment Pharmacol Ther 2012, 36:815-823.